NO20011102L - Bifunctional antibodies and their use in targeting anti-tumor agents - Google Patents
Bifunctional antibodies and their use in targeting anti-tumor agentsInfo
- Publication number
- NO20011102L NO20011102L NO20011102A NO20011102A NO20011102L NO 20011102 L NO20011102 L NO 20011102L NO 20011102 A NO20011102 A NO 20011102A NO 20011102 A NO20011102 A NO 20011102A NO 20011102 L NO20011102 L NO 20011102L
- Authority
- NO
- Norway
- Prior art keywords
- tumor agents
- bifunctional antibodies
- targeting anti
- targeting
- bifunctional
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9819411.1A GB9819411D0 (en) | 1998-09-04 | 1998-09-04 | Antibodies |
| PCT/GB1999/002938 WO2000014119A2 (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their use in targeting anti-tumour agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20011102D0 NO20011102D0 (en) | 2001-03-02 |
| NO20011102L true NO20011102L (en) | 2001-03-05 |
Family
ID=10838416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20011102A NO20011102L (en) | 1998-09-04 | 2001-03-02 | Bifunctional antibodies and their use in targeting anti-tumor agents |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1107995A2 (en) |
| JP (1) | JP2002524470A (en) |
| KR (1) | KR20010072988A (en) |
| CN (1) | CN1315967A (en) |
| AU (1) | AU5641299A (en) |
| BG (1) | BG105293A (en) |
| BR (1) | BR9913429A (en) |
| CA (1) | CA2341753A1 (en) |
| EA (1) | EA200100311A1 (en) |
| GB (1) | GB9819411D0 (en) |
| HR (1) | HRP20010154A2 (en) |
| HU (1) | HUP0104091A2 (en) |
| ID (1) | ID28873A (en) |
| IL (1) | IL141524A0 (en) |
| MX (1) | MXPA01002349A (en) |
| NO (1) | NO20011102L (en) |
| PL (1) | PL346861A1 (en) |
| TR (2) | TR200103405T2 (en) |
| WO (1) | WO2000014119A2 (en) |
| ZA (1) | ZA200101574B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210056288A (en) | 2018-06-01 | 2021-05-18 | 타유 후아시아 바이오테크 메디컬 그룹 컴퍼니 리미티드 | Compositions for treating diseases or conditions and uses thereof |
| EP3826673A4 (en) * | 2018-07-26 | 2022-03-09 | Tayu Huaxia Biotech Medical Group Co., Ltd. | Compositions and methods for imaging |
| CN110811820B (en) * | 2019-12-11 | 2022-07-12 | 江西华晨医疗设备有限公司 | Straight rod type flushing and suction electrocoagulation cutter |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
| IL89491A0 (en) * | 1988-11-17 | 1989-09-10 | Hybritech Inc | Bifunctional chimeric antibodies |
| US5217713A (en) * | 1988-12-27 | 1993-06-08 | Takeda Chemical Industries, Ltd. | Cytotoxic bispecific monoclonal antibody, its production and use |
| CA2069439A1 (en) * | 1989-12-15 | 1991-06-16 | Susumu Iwasa | Monoclonal antibodies, their production and use |
| JPH05184383A (en) * | 1990-06-19 | 1993-07-27 | Dainabotsuto Kk | Bispecific antibody |
| EP0981748A4 (en) * | 1997-02-26 | 2002-09-18 | Ban-An Khaw | Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
-
1998
- 1998-09-04 GB GBGB9819411.1A patent/GB9819411D0/en not_active Ceased
-
1999
- 1999-09-06 MX MXPA01002349A patent/MXPA01002349A/en not_active Application Discontinuation
- 1999-09-06 PL PL99346861A patent/PL346861A1/en not_active Application Discontinuation
- 1999-09-06 EP EP99943138A patent/EP1107995A2/en not_active Withdrawn
- 1999-09-06 TR TR2001/03405T patent/TR200103405T2/en unknown
- 1999-09-06 CA CA002341753A patent/CA2341753A1/en not_active Abandoned
- 1999-09-06 EA EA200100311A patent/EA200100311A1/en unknown
- 1999-09-06 ID IDW20010752A patent/ID28873A/en unknown
- 1999-09-06 JP JP2000568876A patent/JP2002524470A/en active Pending
- 1999-09-06 AU AU56412/99A patent/AU5641299A/en not_active Abandoned
- 1999-09-06 HU HU0104091A patent/HUP0104091A2/en unknown
- 1999-09-06 WO PCT/GB1999/002938 patent/WO2000014119A2/en not_active Application Discontinuation
- 1999-09-06 IL IL14152499A patent/IL141524A0/en unknown
- 1999-09-06 TR TR2001/00651T patent/TR200100651T2/en unknown
- 1999-09-06 BR BR9913429-2A patent/BR9913429A/en not_active IP Right Cessation
- 1999-09-06 KR KR1020017002437A patent/KR20010072988A/en not_active Application Discontinuation
- 1999-09-06 CN CN99810368A patent/CN1315967A/en active Pending
-
2001
- 2001-02-26 ZA ZA200101574A patent/ZA200101574B/en unknown
- 2001-02-26 BG BG105293A patent/BG105293A/en unknown
- 2001-03-02 NO NO20011102A patent/NO20011102L/en unknown
- 2001-03-02 HR HR20010154A patent/HRP20010154A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1315967A (en) | 2001-10-03 |
| WO2000014119A3 (en) | 2000-11-30 |
| NO20011102D0 (en) | 2001-03-02 |
| GB9819411D0 (en) | 1998-10-28 |
| AU5641299A (en) | 2000-03-27 |
| ZA200101574B (en) | 2002-02-26 |
| ID28873A (en) | 2001-07-12 |
| KR20010072988A (en) | 2001-07-31 |
| BR9913429A (en) | 2001-09-25 |
| JP2002524470A (en) | 2002-08-06 |
| MXPA01002349A (en) | 2003-10-15 |
| TR200103405T2 (en) | 2002-06-21 |
| TR200100651T2 (en) | 2001-07-23 |
| CA2341753A1 (en) | 2000-03-16 |
| EA200100311A1 (en) | 2001-08-27 |
| HRP20010154A2 (en) | 2002-02-28 |
| EP1107995A2 (en) | 2001-06-20 |
| PL346861A1 (en) | 2002-03-11 |
| WO2000014119A2 (en) | 2000-03-16 |
| IL141524A0 (en) | 2002-03-10 |
| BG105293A (en) | 2001-12-29 |
| HUP0104091A2 (en) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20000700D0 (en) | Interleukin-18 proteins and their preparation and use | |
| DK1454907T3 (en) | Quninazoline and pyridopyrmidine derivatives | |
| NO983965D0 (en) | Polymer-organolay composites and their preparation | |
| IS5696A (en) | Antibodies against CD23, their derivatives and their therapeutic use | |
| NO20014560D0 (en) | Quinasolines and their therapeutic use | |
| DK0915880T3 (en) | Azolotriazines and pyrimidines | |
| IS6411A (en) | Kaspasa inhibits and their use | |
| DK0869126T3 (en) | Dithioland derivatives, their preparation and their therapeutic effect | |
| DK1019358T4 (en) | 3,3-diarylpropylamines, their use and preparation | |
| NO20001323D0 (en) | Dipeptide-apoptosis inhibitors and their use | |
| NO991150D0 (en) | Pyrazolopyrimidines and pyrazolotriazines | |
| FI19992753A (en) | Procedure in recipient and one recipient | |
| TR199800117A3 (en) | Isaksazol- and crotonacitamide derivatives and their use. | |
| NO20004274L (en) | Protease-activated receptor 4 and its use | |
| NO986174L (en) | Triazine derivatives and their use | |
| NO975020D0 (en) | Azacycloalkane derivatives, their preparation and their use in therapy | |
| FI970887A (en) | Reception procedure and recipients | |
| DK1025100T3 (en) | 3-substituted tetrahydropyridopyrimidinone derivatives, their preparation and their use | |
| FI102230B1 (en) | Reception procedure and recipients | |
| NO985806D0 (en) | Chitinase Materials and Methods | |
| NO20011102D0 (en) | Bifunctional antibodies and their use in targeting anti-tumor agents | |
| NO984921D0 (en) | Tienopyridine derivatives and their use | |
| NO976006D0 (en) | Combined longitudinal and transverse tracking | |
| SE9802929D0 (en) | Device in connection with pacers II | |
| FI972707A0 (en) | Kula and foerfarande Foer framstaellning daerav |